Last update 25 May 2025

SBI-810

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
SBI 810, SBI810
Target
ERK x NMDA receptor x NTSR1
Action
inhibitors, antagonists, agonists
Mechanism
ERK inhibitors(ERK subfamily inhibitors), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists), NTSR1 agonists(Neurotensin receptor 1 agonists)
Therapeutic Areas
Nervous System DiseasesOther Diseases
Active Indication
Acute PainChronic PainOpioid abuse
Inactive Indication-
Originator Organization
Duke University Medical Center
Active Organization
Duke University Medical Center
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC27H34N4O2
InChIKeyTVMPWGASZCIMMZ-UHFFFAOYSA-N
CAS Registry1849603-79-7

Related

100 Clinical Results associated with SBI-810
Login to view more data
100 Translational Medicine associated with SBI-810
Login to view more data
100 Patents (Medical) associated with SBI-810
Login to view more data
1
Literatures (Medical) associated with SBI-810
12 Sep 2019Journal of medicinal chemistryQ1 · MEDICINE
Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators
Q1 · MEDICINE
100 Deals associated with SBI-810
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute PainPreclinical
United States
Duke University Medical Center
15 May 2025
Chronic PainPreclinical
United States
Duke University Medical Center
15 May 2025
Opioid abusePreclinical
United States
Duke University Medical Center
15 May 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free